Last Posted: Mar-22-2023 10:09:59

Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
Ewan C Goligher et al. JAMA 2023 3
The effect of SARS-CoV-2 variant on respiratory features and mortality.
Thomas D Hughes et al. Scientific reports 2023 3 (1) 4503
COVID-19 Forecasting and Mathematical Modeling
CDC, March 2023
School-Based Interventions to Increase Student COVID-19 Vaccination Coverage in Public School Populations with Low Coverage - Seattle, Washington, December 2021-June 2022.
Tarayn Fairlie et al. MMWR. Morbidity and mortality weekly report 2023 3 (11) 283-287

Jose Arturo Molina-Mora et al. Frontiers in public health 2023 3 1095202
Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks.
Shubhangi Kandwal et al. Virology 2023 3 97-115
Learning From COVID-19 to Improve Surveillance for Emerging Threats.
Daniel B Jernigan et al. American journal of public health 2023 3 e1-e3
COVID-origins study links raccoon dogs to Wuhan market: what scientists think
Mallapaty S. Nature, Mar 21, 2023.
Genetic evidence of susceptible wildlife in SARS-CoV-2 positive samples at the Huanan Wholesale Seafood Market, Wuhan: Analysis and interpretation of data released by the Chinese Center for Disease Control
Crits-Christoph A, et al. Zenodo, Mar 20, 2023.
Searching for SARS-CoV-2 origins: confidence versus evidence
Lancet Microbe editorial, March 20, 2023
An AI-enabled research support tool for the classification system of COVID-19.
Tiwari Arti, et al. Frontiers in public health 2023 0 0. 1124998
Using Wearable Technology to Quantify Physical Activity Recovery: Secondary Report From the AFTER (App-Facilitated Tele-Rehabilitation) Program for COVID-19 Survivors Randomized Study.
Churchill Laura, et al. JMIR rehabilitation and assistive technologies 2023 0 0. e43436
Covid-19 variants of concern and pregnancy.
Stock Sarah J, et al. BMJ medicine 2023 0 0. (1) e000151
Covid-19: virology, variants, and vaccines.
Young Megan, et al. BMJ medicine 2023 0 0. (1) e000040
All Latest
About COVID-19 GPH
Site Citation:
Wei Yu, et al. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.


Sign up Email Alert
Special Topics
In PHGKB Databases
Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations and response to COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science, digital health, machine learning and predictive analytic methods (not involving genomics) in discovery, clinical and public health investigations and response to COVID-19
Following categories are annotated by LitCovid from NCBI NIH.
Mechanism | Underlying cause(s) of covid-19 infections and transmission & possible drug mechanism of action |
Transmission | Characteristics and modes of covid-19 transmissions, such as human-to-human |
Diagnosis | Disease assessment through symptoms, test results, and radiological features |
Prevention | Prevention, control, response and management strategies |
Case Report | Descriptions of specific patient cases |
Forecasting | Modelling and estimating the trend of covid-19 spread |
Health Equity | Relevant to health equity. Search terms are derived from a list provided by the Association for Territorial Health Officials which include terms such as diversity, health disparities, and others. |
Vaccine | Relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages |
Variant | Relevant to SARS-CoV-2 variants and their impact on public health. For additional information on variants COVID-19. Check out CDC New Variants of the Virus that Causes COVID-19 page |
Surveillance | Relevant to SARS-CoV-2 public health surveillance and tracking. For additional information on COVID-19 surveillance, check out CDC COVID-19 Data Tracker |
Wei Yu, Emily Drzymalla, Marta Gwinn and Muin J. Khoury. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Genomics and Precision Public Health to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: